期刊文献+

抑癌基因TSPYL5在胃癌中的表达及与远期生存的关系 被引量:1

The relationship between expression and long term survival of tumor suppressor gene TSPYL5 in gastric cancer
下载PDF
导出
摘要 目的研究胃癌组织及其邻近胃组织中睾丸特异性Y样蛋白5(testis-specific Y-like protein 5,TSPYL5)的表达与预后及多个临床病理变量之间的关系,同时分析其是否在胃癌远期生存的危险因素中具有意义。方法采用RT-PCR方法检测44例胃癌组织、癌旁胃正常黏膜组织中TSPYL5 mRNA的表达,分析其表达与胃癌相关临床病理变量的关系。结果与癌旁组织相比,胃癌组织中TSPYL5表达明显下调的有24例,占总数的54.5%。TSPYL5的表达与TNM分期、淋巴转移及是否远处转移有关,而与肿瘤的浸润深度、大小及患者性别、年龄等无关(P<0.05)。肿瘤组织与癌旁组织的TSPYL5表达量相比,其表达下调者的DFS远低于无明显变化及上调者(P=0.01)。经单因素和多因素COX分析表明,TSPYL5可作为胃癌的独立预测因素(P<0.001)。结论 TSPYL5作为抑癌基因,其表达缺失参与了胃癌的发生发展,同时TSPYL5可作为判断胃癌预后的重要分子标志。 Objective To study the relationship between the expression of TSPYL5 ( testis-specific Y-like protein 5,TSPYL5)in gastric carcinoma and adjacent gastric tissues and the long term survival. Our study is to investigate the clinical significances of expression of TSPYL5 in gastric cancer. Methods The mRNA level of TSPYL5 in 44 matched samples comprising primary gastric carcinoma and paired non-cancerous mucosa were detected and compared by quantitative RT-PCR. Then the correlations of mRNA level of TSPYL5 with the clini-copathological characteristics and prognosis of patients with gastric cancer were analyzed. Results The rate of TSPYL5 mRNA in the primary gastric cancer tissues was significantly higher than that in the adjacent non-can-cerous tissues(54. 5%). mRNA expression of TSPYL5 was associated with certain clinical-pathologic variables such as advancing TNM stage, lymphatic metastasis, distant metastasis. We obtained the expression levels ratio of cancer tissue and adjacent non-cancerous tissues and found the lower ratio with a lower Disease-Free Survival (DFS)(P〈0. 001). TSPYL5,as a tumor suppressor gene, remained a statistically-significant prognostic marker&amp;nbsp;in the COX regression analysis. Conclusion Down-expression of TSPYL5 had a significant effect on develop-ment and progress in gastric cancer,which can be used to prognose gastric carcinoma.
出处 《中国肿瘤外科杂志》 CAS 2015年第5期278-281,298,共5页 Chinese Journal of Surgical Oncology
基金 六大人才高峰(2013-WSW-028)
关键词 TSPYL5 抑癌基因 甲基化 胃癌 预后 TSPYL5 tumor suppressor gene methylation gastric cancer prognostic
  • 相关文献

参考文献18

  • 1Necula LG, Mambet C, Albulescu R, et al. Epigenetics in gastric carcinogenesis : tet genes as important players [ J ]. J Immunoassay Immunochem,2015,36 ( 5 ) :445-455. 被引量:1
  • 2王中秋,许林.DNA甲基化在非小细胞肺癌诊断和治疗中的应用[J].中国肿瘤外科杂志,2010,2(1):42-46. 被引量:3
  • 3Liu M, Ingle JN, Fridley BL, et al. TSPYL5 SNPs : association with plasma estradiol concentrations and aromatase expression [ J ]. Mo! Endocrinol, 2013,27 ( 4 ) : 657-670. 被引量:1
  • 4Vogel T, Dittrich O, Mehraein Y, et al. Murine and human TSPYL genes: novel members of the TSPY-SET-NAP1L1 family[ J]. Cy- togenet Cell Genet, 1998,81 (3-4) :265-270. 被引量:1
  • 5Lyu JH,Park DW, Huang B, et al. RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway[J]. J Cell Biochem, 2015,116(2) :260-267. 被引量:1
  • 6Epping MT, Meijer LA, Krijgsman O, et al. TSPYL5 suppresses p53 levels and function by physical interaction with USP7 [ J]. Nat Cell Bio1,2011,13 ( 1 ) : 102-108. 被引量:1
  • 7Kim TY, Zhong S, Fields CR, et al. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma [ J ]. Cancer Res, 2006,66 ( 15 ) : 7490-7501. 被引量:1
  • 8Vachani A, Nebozhyn M, Singhal S, et al. A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma [ J ]. Clin Cancer Res, 2007,13 ( 10 ) : 2905-2915. 被引量:1
  • 9Jung Y, Park J, Bang YJ, et al. Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers [ J ]. Lab In- vest,2008,88 (2) :153-160. 被引量:1
  • 10Fujii-Nakata T, Ishimi Y, Okuda A, et al. Functional analysis of nucleosome assembly protein, NAP-1. The negatively charged COOH-terminal region is not necessary for the intrinsic assembly activity [ J ]. J Biol Chem, 1992,267 ( 29 ) : 20980 -20986. 被引量:1

二级参考文献22

  • 1Buysschaert I,Schmidt T,Boncal C,et al.Genetics,epigenetics and pharmaco-(epi) genomies in angiogenesis[J].J Cell Mol Med,2008,12(6B):2533-2551. 被引量:1
  • 2Humeniuk R,Mishra PJ,Bertino JR,et al.Molecular targets for epigenetic therapy of cancer[J].Curr Pharm Biotechnol,2009,10(2):161-165. 被引量:1
  • 3Herman JG,Baylin SB.Gene silencing in cancer in association with promoter hypermethylation[J].N Engl J Med,2003,349(21):2042-2054. 被引量:1
  • 4Feinberg AP,Tycko B.The history of cancer epigenetics[J].Nat Rev Cancer,2004,4(2):143-153. 被引量:1
  • 5Laird PW.The power and the promise of DNA methylation markers[J].Nat Rev Cancer,2003,3(4):253-266. 被引量:1
  • 6Usadel H,Brabender J,Danenberg KD,et al.Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue,serum,and plasma DNA of patients with lung cancer[J].Cancer Bes,2002,62(2):371-375. 被引量:1
  • 7Hsu HS,Chen TP,Hung CH,et al.Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma[J].Cancer,2007,110(9):2019-2026. 被引量:1
  • 8Bearzatto A,Conte D,Frattini M,et al.p16(INK4A) Hypermethylation detected by fluorescent methylatian-specific PCR in plasmas from non-small cell lung cancer[J].Clin Cancer Res,2002,8(12):3782-3787. 被引量:1
  • 9Laird PW,Jaenisch R.The role of DNA methylation in cancer genetic and epigeneticsIJ].Annu Rev Genet,1996,30:441-464. 被引量:1
  • 10Fujiwara K,Fujimoto N,Tabata M,et al.Identification of epigenetic aberrant promoter methylatian in serum DNA is useful for early detectian of lung cancer[J].Clin Cancer Res,2005,11(3):1219-1225. 被引量:1

共引文献2

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部